{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:01:04Z","timestamp":1780930864264,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.eururo.2009.05.019","type":"journal-article","created":{"date-parts":[[2009,5,20]],"date-time":"2009-05-20T09:32:08Z","timestamp":1242811928000},"page":"238-245","source":"Crossref","is-referenced-by-count":36,"title":["An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients"],"prefix":"10.1016","volume":"57","author":[{"given":"Davide","family":"Bedognetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Rubagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giario","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Francesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavio","family":"De Cobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Canclini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gallucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Aragona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Di Tonno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Cortellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Martorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lapini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Boccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2009.05.019_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.eururo.2006.08.043","article-title":"Antiandrogens in the treatment of prostate cancer","volume":"51","author":"Wirth","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.05.019_bib2","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0022-5347(05)67032-2","article-title":"Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of follow-up","volume":"164","author":"Iversen","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.05.019_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000019634","article-title":"A randomised comparison of \u2018Casodex\u2019\u00ae (bicalutamide) 150mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer","volume":"33","author":"Tyrrell","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.05.019_bib4","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1200\/JCO.1999.17.7.2027","article-title":"Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study","volume":"17","author":"Boccardo","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2009.05.019_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000139877","article-title":"Adjuvant hormonal treatment\u2014the bicalutamide early prostate cancer program","volume":"41","author":"Wirth","year":"2008","journal-title":"Front Radiat Ther Oncol"},{"key":"10.1016\/j.eururo.2009.05.019_bib6","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/01.ju.0000140159.94703.80","article-title":"Bicalutamide 150mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at a median follow-up of 5.4 year","volume":"172","author":"Wirth","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.05.019_bib7","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S1470-2045(05)70464-2","article-title":"Management of gynaecomastia in patients with prostate cancer: a systematic review","volume":"6","author":"Di Lorenzo","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2009.05.019_bib8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJMcp070677","article-title":"Clinical practice. Gynecomastia","volume":"357","author":"Braunstein","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2009.05.019_bib9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.2005.12.013","article-title":"Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer","volume":"23","author":"Boccardo","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2009.05.019_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.pcan.4500782","article-title":"Prevention and management of bicalutamide-induced gynaecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole","volume":"8","author":"Saltzstein","year":"2005","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2009.05.019_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00280-005-1016-1","article-title":"Exploratory study of drug plasma levels during bicalutamide 150mg therapy coadministered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer","volume":"56","author":"Boccardo","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.eururo.2009.05.019_bib12","first-page":"4277","article-title":"4-OH tamoxifen does not interfere with bicalutamide inhibitory effects on human prostatic cancer cells in vitro","volume":"25","author":"Boccardo","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.eururo.2009.05.019_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.eururo.2007.01.032","article-title":"Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose\u2013response study","volume":"52","author":"Van Poppel","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.05.019_bib14","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1200\/JCO.2006.09.4318","article-title":"Randomized dose-ranging trial at low doses of tamoxifen in hormone replacement therapy users","volume":"25","author":"Decensi","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2009.05.019_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0022-5347(18)38306-X","article-title":"Once weekly tamoxifen in the prevention of gynaecomastia and breast pain secondary to bicalutamide therapy","volume":"171","author":"Eaton","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.05.019_bib16","first-page":"967","article-title":"Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial","volume":"10","author":"Guerrieri-Gonzaga","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2009.05.019_bib17","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.clinthera.2006.12.011","article-title":"The relation between intermittent dosing and adherence: preliminary insights","volume":"28","author":"Kruk","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.eururo.2009.05.019_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.eururo.2009.05.019_bib19","series-title":"Statistical Methods in Medical Research","author":"Armitage","year":"1994"},{"key":"10.1016\/j.eururo.2009.05.019_bib20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijrobp.2004.03.022","article-title":"Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10GY) significantly reduces the incidence of bicalutamide-induced gynaecomastia","volume":"60","author":"Tyrrell","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2009.05.019_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(05)70103-0","article-title":"Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial","volume":"6","author":"Perdon\u00e0","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2009.05.019_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2007.01.031","article-title":"Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose\u2013response study","volume":"52","author":"Fradet","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.05.019_bib23","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/bmj.320.7248.1485","article-title":"Adjuvant irradiation for breast cancer","volume":"320","author":"Kunkler","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2009.05.019_bib24","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/jnci\/djm188","article-title":"Does prophylactic breast irradiation in patients with prostatic cancer influence cardiac toxicity?","volume":"99","author":"Nieder","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2009.05.019_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.eururo.2004.12.003","article-title":"Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer","volume":"47","author":"Van Poppel","year":"2005","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283809005326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283809005326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T07:35:51Z","timestamp":1558337751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283809005326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0302283809005326"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2009.05.019","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}